Dimethyl fumarate vs. fingolimod in multiple sclerosis: an independent, multi-centre, real world, quasi-randomized study

被引：0

作者：

Prosperini, L. ^{[1
]}

Lucchini, M. ^{[2
]}

Bellantonio, P. ^{[3
]}

Bianco, A. ^{[2
]}

Buttari, F. ^{[3
,4
]}

Centonze, D. ^{[3
,4
]}

Cortese, A. ^{[1
]}

De Giglio, L. ^{[1
]}

Fantozzi, R. ^{[3
]}

Ferraro, E. ^{[5
]}

Fornasiero, A. ^{[6
]}

Galgani, S. ^{[7
]}

Gasperini, C. ^{[7
]}

Marfia, G. A. ^{[4
]}

Nociti, V. ^{[2
]}

Pontecorvo, S. ^{[1
]}

Pozzilli, C. ^{[1
]}

Ruggieri, S. ^{[1
]}

Salvetti, M. ^{[6
]}

Sgarlata, E. ^{[1
]}

Mirabella, M. ^{[2
]}

机构：

[1] Sapienza Univ, Rome, Italy

[2] Univ Cattolica Sacro Cuore, Fdn Policlin Univ A Gemelli, Rome, Italy

[3] IRCCS Neuromed, Pozzilli, Italy

[4] Tor Vergata Univ Rome, Rome, Italy

[5] S Filippo Neri Hosp, Rome, Italy

[6] S Andrea Hosp, NESMOS, Ctr Expt Neurol Therapies, Rome, Italy

[7] S Camillo Forlanini Hosp, Rome, Italy

来源：

MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P665

引用

页码：316 / 317

页数：2

共 50 条

[1] Fingolimod vs dimethyl fumarate in multiple sclerosis A real-world propensity score-matched study
Prosperini, Luca
Lucchini, Matteo
Haggiag, Shalom
Bellantonio, Paolo
Bianco, Assunta
Buscarinu, Maria Chiara
Buttari, Fabio
Centonze, Diego
Cortese, Antonio
De Giglio, Laura
Fantozzi, Roberta
Ferraro, Elisabetta
Fornasiero, Arianna
Francia, Ada
Galgani, Simonetta
Gasperini, Claudio
Marfia, Girolama Alessandra
Millefiorini, Enrico
Nociti, Viviana
Pontecorvo, Simona
Pozzilli, Carlo
Ruggieri, Serena
Salvetti, Marco
Sgarlata, Eleonora
Mirabella, Massimiliano
[J]. NEUROLOGY, 2018, 91 (02) : E153 - E161
[2] The real-world patient experience of fingolimod and dimethyl fumarate for multiple sclerosis
Wicks P.
Rasouliyan L.
Katic B.
Nafees B.
Flood E.
Sasané R.
[J]. BMC Research Notes, 9 (1)
[3] Real World Comparison of Patient Adherence and Persistence to Fingolimod vs. Dimethyl Fumarate
Polson, Michael
Lord, Todd
Ko, John
Evangelatos, Themmi
Herrera, Vivian
[J]. NEUROLOGY, 2016, 86
[4] Comparison of Dimethyl Fumarate vs Fingolimod and Rituximab vs Natalizumab for Treatment of Multiple Sclerosis
Hou, Jue
Kim, Nicole
Cai, Tianrun
Dahal, Kumar
Weiner, Howard
Chitnis, Tanuja
Cai, Tianxi
Xia, Zongqi
[J]. JAMA NETWORK OPEN, 2021, 4 (11) : E2134627
[5] Safety, tolerability and effectiveness of dimethyl fumarate in multiple sclerosis: an independent, multicenter, real-world study
Mirabella, M.
Prosperini, L.
Lucchini, M.
Boffa, L.
Borriello, G.
Buscarinu, M. C.
Centonze, D.
Cortese, A.
De Fino, C.
De Giglio, L.
Elia, G.
Fantozzi, R.
Ferraro, E.
Francia, A.
Galgani, S.
Gasperini, C.
Haggiag, S.
Landi, D.
Marfia, G. A.
Millefiorini, E.
Monteleone, F.
Nociti, V.
Salvetti, M.
Sgarlata, E.
Pozzilli, C.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 615 - 616
[6] Seizures in multiple sclerosis: A multi-centre study
Mandalfino, P
Koopman, WJ
Vandervoort, MK
O'Connor, P
Hader, W
Brunet, DG
Murray, TJ
Ebers, GC
[J]. MULTIPLE SCLEROSIS, 1998, 4 (06): : 520 - 520
[7] Comparison of natalizumab vs fingolimod and dimethyl fumarate in the treatment of multiple sclerosis: two year experience
Vollmer, B. L.
Nair, K. V.
Sillau, S.
Corboy, J.
Vollmer, T.
Alvarez, E.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 856 - 857
[8] Comparison of Natalizumab vs Fingolimod and Dimethyl Fumarate in the Treatment of Multiple Sclerosis: Two Year Experience
Vollmer, Brandi
Nair, Kavita
Sillau, Stefan
Corboy, John
Vollmer, Timothy
Alvarez, Enrique
[J]. NEUROLOGY, 2017, 88
[9] Real world data on teriflunomide and dimethyl fumarate treatment of multiple sclerosis
Norborg, H.
Strauss, P.
Myhr, K-M.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 864 - 864
[10] Comparison of rituximab vs fingolimod, dimethyl fumarate and natalizumab in the treatment of multiple sclerosis: two year experience
Vollmer, B.
Nair, K.
Sillau, S.
Corboy, J.
Vollmer, T.
Alvarez, E.
[J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 267 - 268

← 1 2 3 4 5 →